Bernstein: 'We See Fresenius Medical Care (FMS) As a Tactical Buy After the Sell-Off'; PT Raised
Tweet Send to a Friend
Bernstein SocGen Group analyst Lisa Clive raised the price target on Fresenius Medical Care (NYSE: FMS) to $31.50 (from $26.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
